Tutti gli studi
ReclutamentoFASE3INTERVENTISTICO

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

The IMPEDE-PKD study is investigating if a common diabetes medication called metformin could help people with a specific kidney condition called Autosomal Dominant Polycystic Kidney Disease (ADPKD). ADPKD causes cysts to grow in the kidneys, leading to a decline in kidney function over time. Researchers want to see if metformin can slow this decline, improve overall health, and increase quality of life. Currently, treatment options are limited and can have side effects or be expensive. Metformin is an affordable and well-known drug that has shown promise in earlier studies by targeting the way these cysts grow. This large, international study hopes to find a new, effective treatment for ADPKD.

A colpo d'occhio

Stato
Reclutamento
Fase
FASE3
Sponsor
The University of Queensland
Obiettivo di iscrizione
1,174
Inizio
29 Nov 2022
Completamento stimato
01 Dic 2030

Di cosa tratta questo studio?

This study, called IMPEDE-PKD, is looking into a new way to help people with a condition called Autosomal Dominant Polycystic Kidney Disease, or ADPKD. ADPKD is a genetic condition where fluid-filled sacs, called cysts, grow in the kidneys. Over time, these cysts can get bigger and lead to pain, high blood pressure, and eventually, the kidneys not working as well as they should. ADPKD affects many people worldwide and can also lead to other health issues like anxiety and depression.

Currently, there aren't many widely available and affordable treatments for ADPKD. There is one medication approved, but it can have side effects and be expensive. This is where the medication metformin comes in. Metformin is already widely used and trusted to treat type 2 diabetes. However, earlier research has suggested that it might also have properties that could slow down the growth of these kidney cysts in people with ADPKD. If successful, metformin could become a much-needed, affordable, and effective treatment.

This study aims to find out if taking metformin can slow down how quickly kidney function declines in people with ADPKD. If it works, it could significantly reduce serious health problems, improve how long people live, and greatly boost their quality of life. This is a large, international study, and the results could make a big difference for many families affected by ADPKD.

Punti chiave

  • The study explores if metformin can slow ADPKD progression.
  • ADPKD is a genetic kidney disease causing cysts.
  • Metformin is a common, affordable diabetes drug being re-purposed.
  • The goal is to improve quality of life and reduce health problems for ADPKD patients.
  • Participants will be randomly assigned to metformin or a placebo.
  • This is a large, international study that could lead to new treatments.

Chi può essere idoneo?

In general, this study is looking for adults aged 18 to 70 who have been diagnosed with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Your kidneys need to be working within a certain range – not too healthy, but not too far along in the disease – to be considered. The doctors will also look at whether your ADPKD shows signs of progressing, either because your kidneys are a certain size, or if your kidney function has been declining over time. They will use specific measurements to figure this out.

However, you won't be able to join if you have diabetes, very high blood pressure that isn't under control, certain serious heart problems, or some types of liver disease. Your doctor will be able to check all these details to see if this study could be right for you.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Hai tra i 18 e i 70 anni?
  2. Have you been diagnosed with ADPKD?
  3. Do you have a certain level of kidney function (not too early, not too late stage)?
  4. Are there signs that your ADPKD is progressing, or are your kidneys a certain size?
  5. Do you have diabetes, uncontrolled high blood pressure, or significant heart or liver disease (which would exclude you)?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

Taking part in this study means you would be randomly assigned to either receive the study medication (metformin) or a placebo (a dummy pill that looks like the real medication but has no active ingredients). This is to fairly compare if metformin is effective. You will have regular visits to the clinic for check-ups, blood tests, and scans to monitor your kidney function and overall health. You'll need to take the study medication as instructed. The total duration of your participation in the study, including all follow-up appointments, will be explained by the study team, but typically clinical trials involve multiple visits over several years.

Rischi e benefici potenziali

Participating in this study might offer the potential benefit of slowing down the progression of your kidney disease, which could improve your long-term health and quality of life. However, as with any medication, there's a possibility of side effects from metformin, which the study team will explain in detail. There's also the chance the treatment might not be effective for you. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (49)

  • Renal Research
    Codice postale verificato
    Gosford, Australia· Attivo ma non reclutante
  • Royal Prince Alfred Hospital
    Codice postale verificato
    Sydney, Australia· Attivo ma non reclutante
  • Royal North Shore Hospital
    Codice postale verificato
    Sydney, Australia· Attivo ma non reclutante
  • Westmead Hospital - Western Sydney Local Health District
    Codice postale verificato
    Sydney, Australia· Attivo ma non reclutante
  • Bundaberg Hospital
    Codice postale verificato
    Bundaberg, Australia· Attivo ma non reclutante
  • Townsville University Hospital
    Codice postale verificato
    Douglas, Australia· Attivo ma non reclutante
  • Royal Brisbane and Women's Hospital
    Codice postale verificato
    Herston, Australia· Attivo ma non reclutante
  • Princess Alexandra Hospital
    Codice postale verificato
    Woolloongabba, Australia· Attivo ma non reclutante
  • Ospedale Reale di Adelaide
    Codice postale verificato
    Adelaide, Australia· Attivo ma non reclutante
  • Royal Melbourne Hospital
    Codice postale verificato
    Melbourne, Australia· Attivo ma non reclutante
  • Austin Health
    Codice postale verificato
    Melbourne, Australia· Attivo ma non reclutante
  • Monash Medical Centre
    Codice postale verificato
    Melbourne, Australia· Attivo ma non reclutante

Domande comuni

What is ADPKD?

ADPKD stands for Autosomal Dominant Polycystic Kidney Disease. It's a genetic condition where fluid-filled sacs, called cysts, grow in your kidneys, which can make them less effective over time.

What is metformin?

Metformin is a common and affordable medication primarily used to treat type 2 diabetes. This study wants to see if it can also help people with ADPKD.

Will I definitely get metformin if I join?

No, you might receive metformin or a placebo (a dummy pill) as part of a randomised study. This helps researchers fairly compare its effects.

Quanto durerà lo studio?

The study will involve regular visits and taking medication over a period that will be explained to you by the study team. Clinical trials often last several years.

Can I stop being part of the study whenever I want?

Yes, you can choose to leave the study at any time, for any reason. Your decision won't affect your regular medical care.

Come saperne di più

Misa Matsuyama, PhD

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Interessato a partecipare?

Registrati per ricevere aggiornamenti

Condividi i tuoi dettagli e il team di ricerca per "Implementation of Metformin theraPy to Ease Decline of Kidne…" ti contatterà se potresti essere idoneo. Parla sempre con il tuo medico prima di accettare di partecipare.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.